Bg pattern

REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Remifentanil SALA 2 mg powder for concentrate for solution for injection or infusion EFG

Remifentanil

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Remifentanil Sala and what is it used for
  2. What you need to know before you are given Remifentanil Sala
  3. How Remifentanil Sala is given
  4. Possible side effects
  5. Storage of Remifentanil Sala
  6. Contents of the pack and other information

1. What is Remifentanil Sala and what is it used for

Remifentanil Sala contains an active substance called remifentanil. This belongs to a group of medicines called opioids, which are used to relieve pain. Remifentanil Sala differs from other medicines in its group because it has a very rapid onset and very short duration of action.

Remifentanil Sala is used for:

  • to stop pain before and during an operation
  • to stop pain during controlled mechanical ventilation in an Intensive Care Unit (for patients 18 years of age and older).
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Remifentanil Sala

Do not use Remifentanil Sala

  • if you are allergic to remifentanil or any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic to fentanyl analogues (pain-relieving medicines similar to fentanyl and belonging to the class of medicines known as opioids)
  • as an injection into the spinal canal
  • as the only medicine to start anesthesia.

Warnings and precautions

Talk to your doctor before you start using Remifentanil Sala

  • if you are allergic to any other opioid medicine, such as morphine or codeine
  • if you have lung problems (you may be more sensitive to having difficulty breathing)
  • if you are over 65 years old, weak or have low blood volume and/or low blood pressure (you are more sensitive to suffering cardiac disorders).

Talk to your doctor before you start taking remifentanil if:

  • You or someone in your family has ever abused or been dependent on alcohol, prescription drugs, or illegal drugs ("addiction").
  • You are a smoker.
  • You have ever had mood problems (depression, anxiety, or personality disorder) or have been treated by a psychiatrist for other mental illnesses.

This medicine contains remifentanil which is an opioid. Repeated use of opioids can make the medicine lose its effectiveness (get used to its effect). It can also cause dependence and abuse, which can lead to a potentially fatal overdose. If you are concerned that you may become dependent on remifentanil, it is important that you consult your doctor.

Occasionally, withdrawal reactions (e.g., rapid heartbeat, high blood pressure, and agitation) have been reported after sudden discontinuation of treatment with this medicine, especially when treatment was administered for more than 3 days (see also section 4. Possible side effects). If you experience these symptoms, your doctor may resume treatment with the medicine and gradually reduce the dose.

If you are not sure if any of the above applies to you, consult your doctor or nurse before you are given Remifentanil Sala.

Other medicines and Remifentanil Sala

Tell your doctor if you are using, have recently used, or might use any other medicines, including those obtained without a prescription. This includes herbal medicines.

This is because remifentanil can interact with other medicines and cause side effects.

In particular, tell your doctor or pharmacist if you are taking:

  • medicines for the heart or blood pressure, such as beta-blockers (this includes atenolol, metoprolol, carvedilol, propranolol, and bisoprolol) or calcium channel blockers (these include amlodipine, diltiazem, and nifedipine).
  • medicines to treat depression, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). It is not recommended to use these medicines at the same time as remifentanil, as they may increase the risk of serotonin syndrome, a potentially fatal disease.

The concomitant use of Remifentanil Sala and sedative medicines, such as benzodiazepines or other related medicines, increases the risk of drowsiness, difficulty breathing (respiratory depression), coma, and can put the patient's life at risk. Due to this, concomitant use with these medicines should only be considered when other treatment options are not possible. The concomitant use of opioids and other medicines used to treat epilepsy, nerve pain, or anxiety (gabapentin and pregabalin) increases the risk of opioid overdose and respiratory depression, and can be potentially fatal.

However, if your doctor prescribes Remifentanil Sala along with sedative medicines, they will limit the dose and duration of treatment.

Tell your doctor about all sedative medicines you are taking and closely follow the recommended dosage provided by your doctor. It may be useful for you to inform a family member or close friend of the signs and symptoms indicated above. Contact your doctor when you experience these symptoms.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. Your doctor will weigh the benefit to you against the risk to your baby of receiving this medicine while pregnant.

You must stop breastfeeding your baby for 24 hours after receiving this medicine. If you express breast milk during this period, you must discard it and not give it to your baby.

If you receive this medicine during childbirth or shortly before delivery, it may affect your baby's breathing. You and your baby will be monitored for signs of excessive sleepiness or difficulty breathing.

Driving and using machines

If you are only in the hospital during the day, your doctor will tell you how long you should wait before leaving the hospital or driving. It may be dangerous to drive too soon after an operation.

After receiving Remifentanil Sala, you should not drink alcohol until you have fully recovered.

3. How Remifentanil Sala is given

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

This medicine should never be self-administered. This medicine will always be administered by qualified personnel.

Remifentanil can be administered:

  • as a single injection into a vein
  • as a continuous infusion into a vein. This is when the medicine is administered slowly over a longer period of time.

The way you are given the medicine and the dose you receive will depend on:

  • the procedure or treatment you are having in the Intensive Care Unit
  • how much pain you have.

The dose varies from patient to patient. No dose adjustment is required in patients with kidney and liver problems.

If you are given too much Remifentanil Sala

The effects of Remifentanil Sala are closely monitored throughout the operation and in intensive care, and appropriate measures will be taken immediately if you receive too much.

After your operation

Tell your doctor or nurse if you have pain. If you have pain after your procedure, you may be given other pain-relieving medicines.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects may occur with this medicine.

Allergic reactions including anaphylaxis: These are rare (may affect up to 1 in 1,000 people who use Remifentanil Sala). The signs include:

  • sudden attacks of sneezing and pain or feeling of pressure in the chest
  • swelling of the eyelids, face, lips, mouth, or tongue
  • hives with lumps or rash on any part of your body
  • a faint

If you experience any of these symptoms, contact a doctor urgently.

Tell your doctor as soon as possible if you feel any of the following effects:

Very common (may affect more than 1 in 10 people)

  • muscle stiffness
  • low blood pressure
  • nausea or vomiting

Common (may affect up to 1 in 10 people)

  • slow heart rate
  • shallow or temporary stop in breathing
  • itching
  • coughing

Uncommon (may affect up to 1 in 100 people)

  • lack of oxygen
  • constipation

Rare (may affect up to 1 in 1,000 people)

  • in patients receiving Remifentanil Sala along with other anesthetic medicines, cardiac arrest has been detected, usually preceded by a decrease in heart rate.

Unknown(cannot be estimated from the available data)

  • physical need for Remifentanil Sala (dependence) or need to increase doses over time to achieve the same effect (tolerance)
  • seizures (convulsions)
  • a type of irregular heartbeat (atrioventricular block)
  • irregular heartbeat (arrhythmia)

Side effects that may occur after your operation:

Common

  • chills
  • increased blood pressure

Uncommon

  • pain

Rare

  • feeling of extreme calm or drowsiness (sedation)

Unknown

Withdrawal syndrome (may manifest with the appearance of the following side effects: increased heart rate, high blood pressure, feeling of agitation or restlessness, nausea, vomiting, diarrhea, anxiety, chills, tremors, and sweating).

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse, even if it is possible that the side effects are not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Remifentanil Sala

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the vial and carton after EXP. The expiry date is the last day of the month shown.

Do not store above 30°C.

The chemical and physical stability of the reconstituted solution has been demonstrated for 24 hours at 25°C.

The chemical and physical stability of the diluted solution has been demonstrated for 4 hours at 25°C.

From a microbiological point of view, the product should be used immediately. If not used immediately, the storage times and conditions are the responsibility of the user and normally should not exceed 24 hours at 2-8°C, unless reconstitution/dilution has taken place in controlled and validated aseptic conditions.

Do not use Remifentanil Sala if you notice any signs of deterioration after reconstitution.

Once reconstituted, Remifentanil Sala should be used immediately. Any unused diluted solution should be discarded. Medicines should not be disposed of via wastewater or household waste. Your doctor or nurse will dispose of any medicine that you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Remifentanil Sala

  • The active substance is remifentanil hydrochloride.
  • The other ingredients are: glycine and hydrochloric acid 37% (for pH adjustment).

After reconstitution as indicated, each ml contains 1 mg of remifentanil.

Appearance and pack of the product

Remifentanil is a white or off-white powder for concentrate for solution for injection or infusion.

Packs of 5 vials.

Marketing authorization holder and manufacturer

Laboratorio Reig Jofré, S.A.

C/ Gran Capitán, 10

08970 Sant Joan Despí (Barcelona)

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Denmark: Remifentanil Reig Jofre 2 mg powder for concentrate for solution for injection or infusion, solution

Norway: Remifentanil Reig Jofre 2 mg powder for concentrate for solution for injection or infusion, solution

Spain: Remifentanilo Sala 2 mg powder for concentrate for solution for injection or infusion EFG

Sweden: Remifentanil Reig Jofre 2 mg powder for concentrate for solution for injection or infusion, solution

Date of last revision of this leaflet:May 2022

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

----------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Remifentanil Sala 2 mg powder for concentrate for solution for injection or infusion

Handling and use instructions

This medicine should be reconstituted by adding 2 ml of injection solution to obtain a reconstituted solution with a remifentanil concentration of approximately 1 mg/ml. After reconstitution, the solution should not be administered as is, but should be diluted again.

Remifentanil Sala is for single use.

For manually performed infusions, remifentanil can be diluted to concentrations ranging from 20 to 250 micrograms/ml (the recommended dilution is 50 micrograms/ml in adults and 20 to 25 micrograms/ml in children over 1 year of age).

For administration via Target-Controlled Infusion (TCI), the recommended dilution of remifentanil is 25 to 50 micrograms/ml.

The dilution of the remifentanil solution can be performed with one of the following injection solutions:

  • Water for injections
  • Glucose 50 mg/ml (5%) injection solution
  • Glucose 50 mg/ml (5%) and sodium chloride 0.9 mg/ml (0.9%) injection solution
  • Sodium chloride 0.9 mg/ml (0.9%) injection solution
  • Sodium chloride 0.45 mg/ml (0.45%) injection solution

The dilution depends on the technical capacity of the infusion device and the patient's expected requirements.

This medicine is compatible with lactated Ringer's injection solution, lactated Ringer's and glucose 50 mg/ml (5%) injection solution, as well as propofol when administered through an intravenous catheter.

Posology

Refer to the Summary of Product Characteristics for information on posology.

Depending on the indications, the recommended dosages are given for adults and/or children (from 1 to 12 years of age) and proposed adjustments for special populations are made.

Overdose treatment

Due to the very short duration of action, the potential for harmful effects due to an overdose is limited to the immediate period following administration. The response to discontinuation of the medicine is rapid, returning to the initial state within 10 minutes.

In case of overdose or suspected overdose, the protocol to follow is as follows:

  • interrupt administration of the medicine,
  • keep the airway open,
  • start assisted ventilation with oxygen,
  • and establish hemodynamic stability.

If respiratory depression is associated with muscle stiffness, a neuromuscular blocker may be required to facilitate ventilation.

To maintain vascular filling, it may be useful to administer certain medicines (vasopressors) to correct hypotension, as well as other supportive measures.

An opioid antagonist such as naloxone can be administered intravenously to treat severe respiratory depression and muscle stiffness. It is unlikely that the duration of respiratory depression after an overdose will be longer than the duration of the opioid antagonist.

Incompatibilities

Remifentanil Sala should only be reconstituted or diluted with the recommended injection solutions.

It should not be reconstituted or mixed with lactated Ringer's injection solution or lactated Ringer's and glucose 50 mg/ml (5%) injection solution.

This medicine should not be mixed with propofol in the same solution for intravenous administration.

This medicine should not be administered within the same intravenous administration line as blood, serum, or plasma.

This medicine should not be mixed with other medicines before administration.

Online doctors for REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION

Discuss questions about REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (1061)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
5.0 (184)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Bulat Garipov

General medicine 15 years exp.

Dr. Bulat Garipov is a radiologist with more than 15 years of experience, specializing in magnetic resonance imaging (MRI). Throughout his professional career, he has worked in leading diagnostic imaging centers, both in on-site practice and teleradiology, which has allowed him to develop a broad and versatile approach to radiology.

Over the years, he has gained solid experience in interpreting MRI studies in various areas, including:

  •  Neuroimaging
  •  Musculoskeletal system (MSK)
  •  Angiography
  •  Abdomen and pelvis
  •  Soft tissues

Additionally, Dr. Garipov is open to new collaboration opportunities in radiology and teleradiology projects. He offers his expertise in MRI, providing both first and second readings of studies, as well as advanced image interpretation, ensuring accurate and high-quality diagnostics.

You could consult Dr. Bulat Garipov in cases where accurate interpretation of MRI studies or a second expert opinion is required. His expertise is especially valuable in cases of suspected neurological conditions, back and joint pain, vascular disorders, as well as in the diagnosis of abdominal and pelvic diseases. The doctor also provides support in complex or unclear clinical situations, including the review of previously performed studies, which helps improve diagnostic accuracy and determine the optimal treatment strategy. A teleradiology format is available, allowing you to receive a professional opinion remotely.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION?
REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION?
The active ingredient in REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION is remifentanil. This information helps identify medicines with the same composition but different brand names.
Who manufactures REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION?
REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION is manufactured by Laboratorio Reig Jofre, S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to REMIFENTANIL SALA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION?
Other medicines with the same active substance (remifentanil) include REMIFENTANIL KERN PHARMA 1 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION, REMIFENTANIL KERN PHARMA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION, REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media